State MI
Clinical Trials in Michigan
Recruiting clinical trials with at least one study location in Michigan. Data updated daily from ClinicalTrials.gov.
Top Conditions in Michigan
NCT07174583 Phase 1, Phase 2
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell L...
Condition
Small-cell Lung Cancer
Enrollment
208 pts
Location
United States, Australia, Brazil
Sponsor
IDEAYA Biosciences
NCT05734066 Phase 1, Phase 2
Recruiting
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants Wit...
Condition
Refractory Ewing Sarcoma
Enrollment
60 pts
Location
United States, Canada
Sponsor
Jazz Pharmaceuticals
NCT06957366 N/A
Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patien...
Condition
Atrial Fibrillation (AF)
Enrollment
920 pts
Location
United States, Belgium, Canada
Sponsor
McMaster University
NCT05410145 Phase 1, Phase 2
Recruiting
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced ...
Condition
KRAS P.G12C
Enrollment
442 pts
Location
United States, Australia, China
Sponsor
D3 Bio (Wuxi) Co., Ltd
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT06683092 N/A
Recruiting
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Condition
Cystic Fibrosis
Enrollment
200 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT07030907 Phase 1
Recruiting
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ova...
Condition
Ovarian Cancer Recurrent
Enrollment
30 pts
Location
United States
Sponsor
Outpace Bio, Inc.
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT02325674 N/A
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
Condition
Generalised Lipodystrophy
Enrollment
100 pts
Location
United States, France, Germany
Sponsor
Amryt Pharma
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT07096674 Phase 2
Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopa...
Condition
Narcolepsy Type 1
Enrollment
90 pts
Location
United States
Sponsor
Centessa Pharmaceuticals (UK)
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07145723 N/A
Recruiting
Supporting Care Partners' Well-Being With Artificial Intelligence (AI) Chatbots
Condition
Caregivers
Enrollment
30 pts
Location
United States
Sponsor
University of Michigan
NCT06580054 Phase 2
Recruiting
Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or ...
Condition
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
Enrollment
22 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT05213676 Phase 4
Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Condition
Congenital Diaphragmatic Hernia
Enrollment
600 pts
Location
United States
Sponsor
The University of Texas Health
NCT01429389 N/A
Recruiting
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
Condition
Down Syndrome
Enrollment
2,000 pts
Location
United States, Canada
Sponsor
Sequenom, Inc.
NCT06050070 N/A
Recruiting
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic ...
Condition
Major Depressive Disorder
Enrollment
70 pts
Location
United States
Sponsor
University of Michigan
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC
NCT04396808 N/A
Recruiting
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men Wit...
Condition
Prostate Cancer
Enrollment
900 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT07058818 N/A
Recruiting
Tailored Resistance Training After Adverse Pregnancy Outcomes
Condition
Postpartum
Enrollment
10 pts
Location
United States
Sponsor
University of Michigan
NCT06275360 Phase 2
Recruiting
Repositioning Immunotherapy in VetArans With Lung Cancer
Condition
Non-Small Cell Lung Cancer
Enrollment
25 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06983470 N/A
Recruiting
Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodu...
Condition
Overactive Bladder
Enrollment
15 pts
Location
United States
Sponsor
University of Michigan
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP